AIFM1 and melanoma: To understand why αTOS acts as a pure agonist in prostate carcinoma but behaves as an antagonist in melanoma, we assessed Reactive Oxygen Species (ROS) and nuclear translocation of the Apoptosis Inducing Factor (AIF).